Cancer Research News: November 6 – November 19

Danish researchers have found that high levels of vitamin B12 may indicate a person is at higher risk of some cancers.
Early data from a trial of an experimental Merck drug show that about half of the advanced melanoma patients treated with the highest dosage showed tumor shrinkage.
Pictures helped to diagnose an infant boy’s retinoblastoma.
Using Google Glass in surgery could assist doctors in comparing medical scans with the actual surgical site.

Cancer Research News: October 23 – November 5

University of Michigan researchers are studying which populations of gut bacteria are closely linked with colon cancer.
A single dose of HPV vaccine may be enough to enable long term protection against new HPV infections, and ultimately, cervical cancer.
A team of researchers in Cambridge, Mass. have used genomic profiling to identify potential targets for pediatric cancer treatments.
Cancer vaccines are turning out to be effective for some advanced cancers that have limited treatment options, like lymphoma and inoperable pancreatic cancer.

View a video segment from CBS Program 60 Minutes of Jack Andraka, a high school student who at age 15 developed a test that might save lives by detecting early pancreatic cancer. (13.36 min)
The October 14 issue (Vol 173, No. 18) of JAMA Internal Medicine features an essay “Academic Medicine in the 21st Century,” by Mark R. Laret, MA, CEO of UCSF Medical Center. The essay is based on his AAMC Chair’s address delivered at the November 2012 AAMC Annual Meeting.
A new nanopharmaceutical may help overcome resistance to certain anticancer drugs.
A new imaging technique that measures metabolic activity in cancer cells can help identify breast cancer subtypes and early treatment response.